Douglas L Hayden
Overview
Explore the profile of Douglas L Hayden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
1751
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gregory D, Han F, Li P, Gritsenko M, Kyle J, Riley F, et al.
Mol Med
. 2024 Dec;
30(1):280.
PMID: 39730996
Vertebrates differ over 100,000-fold in responses to pro-inflammatory agonists such as bacterial lipopolysaccharide (LPS), complicating use of animal models to study human sepsis or inflammatory disorders. We compared transcriptomes of...
2.
Gregory D, Han F, Li P, Gritsenko M, Kyle J, Riley F, et al.
medRxiv
. 2023 Dec;
PMID: 38076828
Vertebrates differ greatly in responses to pro-inflammatory agonists such as bacterial lipopolysaccharide (LPS), complicating use of animal models to study human sepsis or inflammatory disorders. We compared transcriptomes of resting...
3.
Mayer K, Palakshappa J, Peltan I, Andrew J, Gundel S, Ringwood N, et al.
Pilot Feasibility Stud
. 2022 Sep;
8(1):212.
PMID: 36123599
Introduction: We describe a protocol for FIRE CORAL, an observational cohort study that examines the recovery from COVID-19 disease following acute hospitalization with an emphasis on functional, imaging, and respiratory...
4.
Peltan I, Caldwell E, Admon A, Attia E, Gundel S, Mathews K, et al.
Am J Crit Care
. 2021 Oct;
31(2):146-157.
PMID: 34709373
Background: Understanding COVID-19 epidemiology is crucial to clinical care and to clinical trial design and interpretation. Objective: To describe characteristics, treatment, and outcomes among patients hospitalized with COVID-19 early in...
5.
Self W, Semler M, Leither L, Casey J, Angus D, Brower R, et al.
JAMA
. 2020 Nov;
324(21):2165-2176.
PMID: 33165621
Importance: Data on the efficacy of hydroxychloroquine for the treatment of coronavirus disease 2019 (COVID-19) are needed. Objective: To determine whether hydroxychloroquine is an efficacious treatment for adults hospitalized with...
6.
Casey J, Johnson N, Semler M, Collins S, Aggarwal N, Brower R, et al.
Ann Am Thorac Soc
. 2020 Jun;
17(9):1144-1153.
PMID: 32492354
The ORCHID (Outcomes Related to COVID-19 treated with Hydroxychloroquine among In-patients with symptomatic Disease) trial is a multicenter, blinded, randomized trial of hydroxychloroquine versus placebo for the treatment of adults...
7.
Lauer A, Da X, Hansen M, Boulouis G, Ou Y, Cai X, et al.
Brain
. 2017 Nov;
140(12):3139-3152.
PMID: 29136088
Cerebral X-linked adrenoleukodystrophy is a devastating neurodegenerative disorder caused by mutations in the ABCD1 gene, which lead to a rapidly progressive cerebral inflammatory demyelination in up to 60% of affected...
8.
Huang D, Angus D, Moss M, Thompson B, Ferguson N, Ginde A, et al.
Ann Am Thorac Soc
. 2016 Oct;
14(1):124-133.
PMID: 27779896
The Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) trial is a multicenter, randomized trial designed to assess the efficacy and safety of early neuromuscular blockade in patients with moderate to...
9.
Mitchell D, Leder B, Cagliero E, Mendoza N, Henao M, Hayden D, et al.
Am J Clin Nutr
. 2015 Jul;
102(2):385-92.
PMID: 26156733
Background: Epidemiologic data suggest that low serum 25-hydroxyvitamin D [25(OH)D] increases insulin resistance and the risk of type 2 diabetes. Few interventional trials have assessed the effect of vitamin D...
10.
Klein M, Goverman J, Hayden D, Fagan S, McDonald-Smith G, Alexander A, et al.
Ann Surg
. 2014 Apr;
259(5):833-41.
PMID: 24722222
Objective: To determine and compare outcomes with accepted benchmarks in burn care at 6 academic burn centers. Background: Since the 1960s, US morbidity and mortality rates have declined tremendously for...